Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

APPROVED_FOR_MARKETING

Conditions studied: Dravet Syndrome

In brief

The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.

Key facts

Study ID

NCT04437004

Run by

University of California, Los Angeles

Last updated by the study team

2026-04-20

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Genetic diagnosis of Dravet syndrome with intractable seizures despite failing all available medications for seizures.

Where it is running

• University of California, Los Angeles — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.